| Application no. and date | 17829372.6 (espacenet) (Federated) (European Patent Register), 20171205 | | Patent/reg. no. and date | DK/EP 3551617, 20210811 | | Publication date | 20191016 | | Priority no. and date | US 201662430662 P, 20161206 | | EP pub. no. and date |
EP 3551617 20191016 | | Effective date | | | Applicant/owner | CoLucid Pharmaceuticals, Inc., c/o Eli Lilly and Company
Lilly Corporate Center
Indianapolis, IN 46285, US | | Applicant ref. no. | V345999DK00 | | Inventor | ALLIERI, Brigida, c/o Eli Lilly and Company
Lilly Corporate Center
Indianapolis, IN 46285, US,
FAGAN, Paul, c/o Eli Lilly and Company
Lilly Corporate Center
Indianapolis, IN 46285, US,
SHARP, Emma, c/o Johnson Matthey Plc
250 Cambridge Science Park
Milton Road
Cambridge
Cambridgeshire CB4 0WE, GB,
SKWIERCZYNSKI, Raymond, D., c/o Eli Lilly and Company
Lilly Corporate Center
Indianapolis, IN 46285, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/444 (2006.01) , A61P 25/06 (2006.01) , C07D 401/06 (2006.01) | | Title | Sammensætninger og fremgangsmåder relateret til pyridinodylpiperidin-5-HT1F-agonister | | Int. application no. | US2017064652 | | Int. publication no. | WO2018106657 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
